NCT07132892 is a NA clinical trial of Galaflex Lite Scaffold in Tissue Adhesion, sponsored by Jeffrey M. Kenkel.

Who is sponsoring NCT07132892?

NCT07132892 is sponsored by Jeffrey M. Kenkel.

What drugs are being tested in NCT07132892?

Interventions in NCT07132892: Galaflex Lite Scaffold.

What condition does NCT07132892 study?

NCT07132892 studies Tissue Adhesion.

Is NCT07132892 still recruiting?

NCT07132892 is currently enrolling by invitation. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT07132892

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy

ENROLLING BY INVITATION NA Last updated 7 January 2026

What this trial tests

NA trial testing Galaflex Lite Scaffold in Tissue Adhesion in 6 participants. Enrolling by invitation.

Timeline

1 December 2025

Primary endpoint
30 June 2026

31 December 2027

Quick facts

Lead sponsor	Jeffrey M. Kenkel
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	1 December 2025
Primary completion	30 June 2026
Estimated completion	31 December 2027
Sites	1 location across United States

Drugs / interventions tested

Galaflex Lite Scaffold

Conditions studied

Tissue Adhesion — all drugs for Tissue Adhesion →

Sponsor

Jeffrey M. Kenkel

Who can join

Adults 18 to 80, any sex, with Tissue Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is being conducted to objectively assess tissue changes following the use of P4HB in rhytidectomy to understand how the utilization of the surgical mesh may affect tissue mechanical strength and elasticity, wound healing, and scar formation dynamics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07132892 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jeffrey M. Kenkel
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07132892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing